Navigation Links
Dangerous tricksters: Some bacterie use immune cells to reproduce

Macrophages are effective weapons used by our immune system to absorb and digest pathogenic intruders. Some bacteria, however, can subvert this defence mechanism and even multiply within the macrophages. Cell biologists at the University of Bonn have revealed such a strategy in a recently publication in the journal 'Traffic' (Vol. 6, No. 8, August 2005, pp.635-653). Their findings reveal that the pathogens escape the 'stomach' of the macrophages which might otherwise digest them.

Action stations in the horse's lung! A bacterium has just been inhaled into a horse's bronchial tubes, and immune cells are quickly recruited to the spot to neutralise the intruder. Macrophages, cells whose job is to devour such intruders, are attracted by substances typical of bacteria, which surround the microbe like a cloud. As soon as the immune cells have detected the intruder, they cover the bacterium with part of their own cell membrane like a hood, creating a membrane sac in which the intruder is trapped. This 'phagosome' (from Greek phagein = to eat) cuts itself off into the inside of the macrophage and is now the point on which all the macrophage's offensive weaponry is concentrated: the phagosome is flooded with oxygen radicals and acid. Another kind of membrane bags, the lysosomes, merge with the phagosome and confront the microbe with highly reactive digestive enzymes. A few hours after the first alarm bells have rung there is nothing left of the bacterium, and the potential danger has been eliminated.

Multiplication inside the killer

This is what normally happens. However, a whole range of pathogens have become specialised in tricking this very part of the defence mechanism and survive or even multiply in these macrophages which are actually supposed to kill them.

One of these pathogens is Rhodococcus equi. This bacterium can cause a lung disease in young foals which is very similar to tuberculosis in humans. Hence, it is not too surpris ing that Rhodococcus equi is closely related to the tubercle bacillus (Mycobacterium tuberculosis). Since macrophages are the main target of Rhodococcus in the horse's lung, a lot of rhodococci are found there during an infection.

In the Bonn Institute of Cell Biology Eugenia Fernandez and Marco Polidori in Professor Albert Haas's team have been examining why Rhodococcus equi is not killed and digested in macrophages, and is even able to multiply there. In the course of this study the group was able to demonstrate that the rhodococci are able to put prevent the phagosome development inside the macrophage, preventing acidification and merging with the lysosomes. As a result the bacteria are not exposed to the large array of lysosomal digestive enzymes and acid.

Killing the killer

'Basically what this means is that the rhodococci manipulate their host cell, they make it themselves comfartable in an environment free of acid and digestive enzymes and multiply there,' Professor Haas comments. Within a few days after the onset of the infection, the macrophages die of the infection, they disintegrate and release the multiplied pathogens.

The Bonn cell biologists have demonstrated in the past that this cell death is 'necrotic'. This means that cell components escape, attract other immune cells and activating them. Ultimately the result is inflammation and tissue damage. 'It is quite possible that rhodococci do not really mind this,' Professor Haas says, 'since they can then grab a passing macrophage and colonise fresh material.'

The next aim of the Bonn researchers is to investigate which bacterial features are important for preventing the merger of phagosomes and lysosomes, and how the immune system normally successfully eradicates an infection despite all the tricks the bacteria use.

Rhodococci, incidentally, can also cause diseases resembling TB in AIDS patients which may be fatal. 'This is an additional important a spect for our work,' Prof. Haas stresses. 'We assume that our research can contribute to understanding TB in humans.' Unlike foals, however, the vast majority of humans do not need to be afraid of this pathogen. 'In every spadeful of soil from an affected farm there are millions upon millions of rhodococci, yet it practically never happens that healthy humans are successfully infected by them.'


'"/>

Source:University of Bonn


Related biology news :

1. Fox Chase Cancer Center scientists identify immune-system mutation
2. Genetically modified natural killer immune cells attack, kill leukemia cells
3. Studies reveal methods viruses use to sidestep immune system
4. Jumping gene helps explain immune systems abilities
5. Scientists solve structure of key protein in innate immune response
6. Rats infected as newborns grew up vulnerable to memory problems during an immune challenge
7. NYU study reveals how brains immune system fights viral encephalitis
8. Chemists identify immune system mechanism for methamphetamine binges
9. Multi-purpose protein regulates new protein synthesis and immune cell development
10. Genetic defects give the immune system the green light to attack the pancreas
11. Leprosy microbes lead scientists to immune discovery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a ... with the release of its patent-pending calibration device. With ... reliably perform calibrations, securely upload data logs and process ... the customer. "Fighting drunk driving through the ... the public at large, but also for the customer ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CESĀ® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, Inc. ... "Company"), announced that on January 14, 2017 the Board ... which the Company will terminate certain employees associated with ... Inc.  The Company commenced terminations on January 16, 2017 ... days.  The Company may pay severance benefits in certain ...
(Date:1/20/2017)... -- Ginkgo Bioworks, the organism company, announced today ... synthesis and assembly of DNA. The acquisition will ... DNA into Ginkgo,s automated organism engineering foundries, enabling ... new organism designs for application across a wide ... to significantly increase the world,s capacity to cost-effectively ...
(Date:1/19/2017)... LOUISVILLE, Ky. and HOUSTON ... Prenatal Inc. ("NX Prenatal") today announced the formation ... brings together leading clinicians and industry veterans who ... the company as it accelerates development of its ... positioned to provide medical, clinical and strategic guidance ...
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
Breaking Biology Technology: